The peer-authored management source for clinical lab professionals since 1969.
Continuing Education
Diagnostics
Disease
Management
Molecular
Sections
Continuing Education
Diagnostics
Disease
Management
Molecular
Information Technology
Online Exclusives
Special
Magazine
Newsletter
Webinars
White Papers
eBooks
Clinical Laboratory Reference
Videos
Events
Contact
About Us
Magazine Subscription
Newsletter Subscription
Advertise
Contact Us
Affiliated Brands
HEALTHCARE PURCHASING NEWS
HEALTHCARE INNOVATION
Follow us on
https://www.facebook.com/MLOMedicalLaboratoryObserver
https://www.linkedin.com/company/medical-laboratory-observer
https://twitter.com/MedicalLabMLO
Home
Cervical disease screening and detection: emerging techniques in molecular diagnostic assays
MLO Staff
Sept. 1, 2004
About the Author
MLO Staff
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Blood culture contamination in U.S. hospitals
Dear API Abby
Sponsored
A Better Way to Manage Antinuclear Autoantibody Testing
Sponsored
Antinuclear Antibody Testing: How to Manage Loss of HEp-2 IFA Expertise
Trending
Preventing misphenotyping in a patient with warm autoantibody interference: A case report
What is my patient’s volume status? Leveraging plasma volume estimation to guide clinical decisions in and beyond the ICU
Ready or not: Operational readiness for HCID patients
Sponsored Picks
Sponsored
A Better Way to Manage Antinuclear Autoantibody Testing
Sponsored
Antinuclear Antibody Testing: How to Manage Loss of HEp-2 IFA Expertise
Sponsored
Can Clinical Laboratories Improve Patient Care Without Increasing Cost?
Load More Content
